1,014 research outputs found
Criteria for the diagnosis of corticobasal degeneration
Current criteria for the clinical diagnosis of pathologically confirmed corticobasal degeneration (CBD) no longer reflect the expanding understanding of this disease and its clinicopathologic correlations. An international consortium of behavioral neurology, neuropsychology, and movement disorders specialists developed new criteria based on consensus and a systematic literature review. Clinical diagnoses (early or late) were identified for 267 nonoverlapping pathologically confirmed CBD cases from published reports and brain banks. Combined with consensus, 4 CBD phenotypes emerged: corticobasal syndrome (CBS), frontal behavioral-spatial syndrome (FBS), nonfluent/agrammatic variant of primary progressive aphasia (naPPA), and progressive supranuclear palsy syndrome (PSPS). Clinical features of CBD cases were extracted from descriptions of 209 brain bank and published patients, providing a comprehensive description of CBD and correcting common misconceptions. Clinical CBD phenotypes and features were combined to create 2 sets of criteria: more specific clinical research criteria for probable CBD and broader criteria for possible CBD that are more inclusive but have a higher chance to detect other tau-based pathologies. Probable CBD criteria require insidious onset and gradual progression for at least 1 year, age at onset β₯50 years, no similar family history or known tau mutations, and a clinical phenotype of probable CBS or either FBS or naPPA with at least 1 CBS feature. The possible CBD category uses similar criteria but has no restrictions on age or family history, allows tau mutations, permits less rigorous phenotype fulfillment, and includes a PSPS phenotype. Future validation and refinement of the proposed criteria are needed
A linguistic analysis of lying in negative evaluations: The speech act performance of Chinese learners of Korean
μ΄ λ
Όλ¬Έμ μ€κ΅μΈ νκ΅μ΄ νμ΅μμ νκ΅μ΄ νμλ€ μ¬μ΄μ βκ±°μ§λ§β νν μμμ μΈμ΄νμ μΌλ‘ λΆμν μ°κ΅¬μ΄λ€. μ¬κΈ°μ λ§νλ βκ±°μ§λ§βμ΄λ μμ², μ¬κ³Ό, κ±°μ λ±κ³Ό κ°μ ννμ μΌμ’
μΌλ‘μ βλΆμ μ νκ°βμ μνλ©° λν μ°Έμ¬μλ μν©μ κ³ λ €ν μμ βμ μμ κ±°μ§λ§βμ κ°λ¦¬ν€λ κ²μΌλ‘ μ΄ν΄ν μ μμ κ²μ΄λ€. μ°λ¦¬λ μ€κ΅μΈ νκ΅μ΄ νμ΅μ 15λͺ
κ³Ό νκ΅μ΄ νμ 15λͺ
μ λμμΌλ‘ λ΄νμμ±ν
μ€νΈ(DCT)μ λΆμ°μ€λͺ
μ§λ¬Έμ§(QFE)λ₯Ό μ¬μ©νμ¬ νΌμ€νμλ€μ ννμ λΆμνμλ€. νΌμ€νμ μμ λ€μ μ€λͺ
κ³Ό νκ΅μ΄κ΅μ‘ μ λ¬Έκ° λ€μ― λͺ
μ νμ μ μ’
ν©ν΄ βκ±°μ§λ§β ννμ κ°λ €λ΄κ³ ν΅κ³ μ²λ¦¬λ₯Ό λ°νμΌλ‘ λ€μκ³Ό κ°μ κ²°λ‘ μ λλ¬νλ€. νκ΅μ΄ νμλ€μ΄ μ€κ΅μΈ νκ΅μ΄ νμ΅μλ€λ³΄λ€ (μ μμ) κ±°μ§λ§μ λ λ§μ΄ μννλ κ²μΌλ‘ λνλ¬λ€. κ·Έλ¦¬κ³ λ μ§λ¨ λͺ¨λ λΆμ μ νκ°κ° μ¬λ¬Όμ κ΄λ ¨λ κ²½μ°λ³΄λ€ μ¬λμ κ΄λ ¨λ κ²½μ°μ βκ±°μ§λ§β ννμ λ λ§μ΄ μ¬μ©νλ€. κ·Έλ¬λ νμμ μ²μ μ¬μ΄μ μΉμκ΄κ³(distance)λ μνκ΄κ³(power)λ κ±°μ§λ§ μ¬μ©μ μ§μ μ μκ΄ κ΄κ³λ₯Ό 보μ¬μ£Όμ§ μμλ€. μ΄ μ°κ΅¬λ μ§κΈκΉμ§ νν μ°κ΅¬ μ€μμ μλμ μΌλ‘ μ°κ΅¬κ° λΆμ§νλ λΆμ νκ°μ βκ±°μ§λ§β ννμ λν λΆμμ μλνλ€λ μ μμ μλ―Έκ° μλ€. λν νκ΅μ΄ νμμ μ€κ΅μΈ νκ΅μ΄ νμ΅μ μ¬μ΄μ 보μ΄λ νν μνμ μ°¨μ΄λ₯Ό λ¬ΈνμΈμ(cultural awareness)μ κ΄μ μμ ν΄μν΄ λ³Ό μ μλ κ°λ₯μ±λ μ΄μ΄ μ£Όμλ€
Canvass: a crowd-sourced, natural-product screening library for exploring biological space
NCATS thanks Dingyin Tao for assistance with compound characterization. This research was supported by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH). R.B.A. acknowledges support from NSF (CHE-1665145) and NIH (GM126221). M.K.B. acknowledges support from NIH (5R01GM110131). N.Z.B. thanks support from NIGMS, NIH (R01GM114061). J.K.C. acknowledges support from NSF (CHE-1665331). J.C. acknowledges support from the Fogarty International Center, NIH (TW009872). P.A.C. acknowledges support from the National Cancer Institute (NCI), NIH (R01 CA158275), and the NIH/National Institute of Aging (P01 AG012411). N.K.G. acknowledges support from NSF (CHE-1464898). B.C.G. thanks the support of NSF (RUI: 213569), the Camille and Henry Dreyfus Foundation, and the Arnold and Mabel Beckman Foundation. C.C.H. thanks the start-up funds from the Scripps Institution of Oceanography for support. J.N.J. acknowledges support from NIH (GM 063557, GM 084333). A.D.K. thanks the support from NCI, NIH (P01CA125066). D.G.I.K. acknowledges support from the National Center for Complementary and Integrative Health (1 R01 AT008088) and the Fogarty International Center, NIH (U01 TW00313), and gratefully acknowledges courtesies extended by the Government of Madagascar (Ministere des Eaux et Forets). O.K. thanks NIH (R01GM071779) for financial support. T.J.M. acknowledges support from NIH (GM116952). S.M. acknowledges support from NIH (DA045884-01, DA046487-01, AA026949-01), the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program (W81XWH-17-1-0256), and NCI, NIH, through a Cancer Center Support Grant (P30 CA008748). K.N.M. thanks the California Department of Food and Agriculture Pierce's Disease and Glassy Winged Sharpshooter Board for support. B.T.M. thanks Michael Mullowney for his contribution in the isolation, elucidation, and submission of the compounds in this work. P.N. acknowledges support from NIH (R01 GM111476). L.E.O. acknowledges support from NIH (R01-HL25854, R01-GM30859, R0-1-NS-12389). L.E.B., J.K.S., and J.A.P. thank the NIH (R35 GM-118173, R24 GM-111625) for research support. F.R. thanks the American Lebanese Syrian Associated Charities (ALSAC) for financial support. I.S. thanks the University of Oklahoma Startup funds for support. J.T.S. acknowledges support from ACS PRF (53767-ND1) and NSF (CHE-1414298), and thanks Drs. Kellan N. Lamb and Michael J. Di Maso for their synthetic contribution. B.S. acknowledges support from NIH (CA78747, CA106150, GM114353, GM115575). W.S. acknowledges support from NIGMS, NIH (R15GM116032, P30 GM103450), and thanks the University of Arkansas for startup funds and the Arkansas Biosciences Institute (ABI) for seed money. C.R.J.S. acknowledges support from NIH (R01GM121656). D.S.T. thanks the support of NIH (T32 CA062948-Gudas) and PhRMA Foundation to A.L.V., NIH (P41 GM076267) to D.S.T., and CCSG NIH (P30 CA008748) to C.B. Thompson. R.E.T. acknowledges support from NIGMS, NIH (GM129465). R.J.T. thanks the American Cancer Society (RSG-12-253-01-CDD) and NSF (CHE1361173) for support. D.A.V. thanks the Camille and Henry Dreyfus Foundation, the National Science Foundation (CHE-0353662, CHE-1005253, and CHE-1725142), the Beckman Foundation, the Sherman Fairchild Foundation, the John Stauffer Charitable Trust, and the Christian Scholars Foundation for support. J.W. acknowledges support from the American Cancer Society through the Research Scholar Grant (RSG-13-011-01-CDD). W.M.W.acknowledges support from NIGMS, NIH (GM119426), and NSF (CHE1755698). A.Z. acknowledges support from NSF (CHE-1463819). (Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); CHE-1665145 - NSF; CHE-1665331 - NSF; CHE-1464898 - NSF; RUI: 213569 - NSF; CHE-1414298 - NSF; CHE1361173 - NSF; CHE1755698 - NSF; CHE-1463819 - NSF; GM126221 - NIH; 5R01GM110131 - NIH; GM 063557 - NIH; GM 084333 - NIH; R01GM071779 - NIH; GM116952 - NIH; DA045884-01 - NIH; DA046487-01 - NIH; AA026949-01 - NIH; R01 GM111476 - NIH; R01-HL25854 - NIH; R01-GM30859 - NIH; R0-1-NS-12389 - NIH; R35 GM-118173 - NIH; R24 GM-111625 - NIH; CA78747 - NIH; CA106150 - NIH; GM114353 - NIH; GM115575 - NIH; R01GM121656 - NIH; T32 CA062948-Gudas - NIH; P41 GM076267 - NIH; R01GM114061 - NIGMS, NIH; R15GM116032 - NIGMS, NIH; P30 GM103450 - NIGMS, NIH; GM129465 - NIGMS, NIH; GM119426 - NIGMS, NIH; TW009872 - Fogarty International Center, NIH; U01 TW00313 - Fogarty International Center, NIH; R01 CA158275 - National Cancer Institute (NCI), NIH; P01 AG012411 - NIH/National Institute of Aging; Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Scripps Institution of Oceanography; P01CA125066 - NCI, NIH; 1 R01 AT008088 - National Center for Complementary and Integrative Health; W81XWH-17-1-0256 - Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program; P30 CA008748 - NCI, NIH, through a Cancer Center Support Grant; California Department of Food and Agriculture Pierce's Disease and Glassy Winged Sharpshooter Board; American Lebanese Syrian Associated Charities (ALSAC); University of Oklahoma Startup funds; 53767-ND1 - ACS PRF; PhRMA Foundation; P30 CA008748 - CCSG NIH; RSG-12-253-01-CDD - American Cancer Society; RSG-13-011-01-CDD - American Cancer Society; CHE-0353662 - National Science Foundation; CHE-1005253 - National Science Foundation; CHE-1725142 - National Science Foundation; Beckman Foundation; Sherman Fairchild Foundation; John Stauffer Charitable Trust; Christian Scholars Foundation)Published versionSupporting documentatio
- β¦